Suppr超能文献

增殖性糖尿病视网膜病变的玻璃体内新生血管组织:一项免疫组织化学研究。

Intravitreal neovascular tissue of proliferative diabetic retinopathy: an immunohistochemical study.

作者信息

Hosoda Y, Okada M, Matsumura M, Ogino N, Honda Y, Nagai Y

机构信息

Department of Ophthalmology, Kyoto University, Faculty of Medicine, Japan.

出版信息

Ophthalmic Res. 1992;24(5):260-4. doi: 10.1159/000267176.

Abstract

Intravitreal neovascular tissue in 8 cases of proliferative diabetic retinopathy was investigated using immunohistochemical techniques. All 8 cases yielded positive immunoreactivity for type II collagen (vitreous collagen). The intravitreal neovascular tissue was classified into two groups (A or B), depending upon the distribution of type II collagen. In group A (3 cases), blood vessels were entirely surrounded by vitreous collagen, and in group B (5 cases), the vessels proliferated on one side of a mass of vitreous collagen. Type I and III collagens were distributed diffusely within the extracellular space of the tissue, whereas type IV collagen and fibronectin (FN) formed a basement membrane-like foundation for the newly formed vessels. Glial fibrillary acidic protein (GFAP)-immunoreactive cells were not clearly detected in any of the cases. Neovascular tissue typically proliferated on the posterior vitreous surface (as found in group B), but was also found to penetrate the vitreous gel (as found in group A). As neovascular tissue proliferation proceeded, types I, III and IV collagens and FN were produced. Glial cells (GFAP-positive cells) were not essential for neovascular tissue formation.

摘要

采用免疫组织化学技术对8例增殖性糖尿病视网膜病变患者的玻璃体内新生血管组织进行了研究。所有8例患者的II型胶原(玻璃体胶原)免疫反应均呈阳性。根据II型胶原的分布情况,将玻璃体内新生血管组织分为两组(A组或B组)。A组(3例)血管完全被玻璃体胶原包围,B组(5例)血管在一团玻璃体胶原的一侧增殖。I型和III型胶原弥漫分布于组织的细胞外间隙,而IV型胶原和纤连蛋白(FN)为新形成的血管形成了基底膜样基础。在任何病例中均未清晰检测到胶质纤维酸性蛋白(GFAP)免疫反应阳性细胞。新生血管组织通常在玻璃体后表面增殖(如B组所见),但也发现其可穿透玻璃体凝胶(如A组所见)。随着新生血管组织增殖的进行,I型、III型和IV型胶原以及FN产生。胶质细胞(GFAP阳性细胞)对于新生血管组织的形成并非必需。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验